:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Melih Can Gül
Format:	Recurso digital
Language:	English
Published:	Zenodo 2025
Online Access:	https://doi.org/10.5281/zenodo.17374498
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hematology/Oncology and Stem Cell Therapy
Published: (2026)

Integrating Nature Into Oncology: Enhancing Hematological Malignancies Therapies With Natural Medicine
by: Yaoyao Tian, et al.
Published: (2025)

Strategies to Enhance CAR ‐T Cell Persistence in Hematologic Malignancies: From Molecular Design to Clinical Optimization
by: Mengqi Yu, et al.
Published: (2025)

Atypical Lymphocytosis Induced by T Cell‐Engaging Therapy in Patients With Hematological Malignancies
by: Tae‐Shin Kim, et al.
Published: (2025)

Response to Methodological Concerns Regarding Eligibility Criteria and Study Selection in a Systematic Review and Meta‐Analysis of CAR T‐Cell Therapy for Hematologic Malignancies
by: Charalampos Filippatos, et al.
Published: (2026)

From Bench to Bedside: Emerging Paradigms in CAR‐T Cell Therapy for Solid Malignancies
by: Yang Chen, et al.
Published: (2025)

Efficacy and Safety of Bendamustine Versus Fludarabine and Cyclophosphamide as Lymphodepleting Regimens for CAR ‐T Therapy in Hematological Malignancies: A Systematic Review and Meta‐Analysis
by: Akihiro Miyashita, et al.
Published: (2026)

Oncolog-Hematolog.ro
Published: (2021)

Journal of Hematology & Oncology
Published: (2008)

Experimental Hematology & Oncology
Published: (2012)

International Journal of Hematology-Oncology and Stem Cell Research
Published: (2020)

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity
by: Omar Alqaisi, et al.
Published: (2026)

Hematology, Transfusion and Cell Therapy
Published: (2018)

Cytomegalovirus Infection After Chimeric Antigen Receptor T‐Cell Therapy or Bispecific Antibody Treatment for Hematologic Malignancies
by: Juhui Han, et al.
Published: (2025)

healthbook TIMES. Oncology Hematology
Published: (2022)

Clinical Pediatric Hematology-Oncology
Published: (2020)

Pediatric Hematology Oncology Journal
Published: (2017)

ESMO Gastrointestinal Oncology
Published: (2024)

Expert Perspective: Hematologic Malignancies and Vasculitis
by: Michelle L. Robinette, et al.
Published: (2025)

The Neurocognitive Impact of CAR T Cell Therapy in Hematological Cancers: A Systematic Review of Cognitive Function, Quality of Life, and Psychological Outcomes
by: Ashvath Arumugam Pillai, et al.
Published: (2025)

Using test particle sum rules to construct accurate functionals in classical Density Functional Theory
by: Gül, Melih, et al.
Published: (2024)

Using test particle sum rules to improve approximations in classical DFT : White-Bear and White-Bear mark II versions of the Lutsko Functional
by: Gül, Melih, et al.
Published: (2026)

CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View
by: Sara Capolla, et al.
Published: (2025)

Late Immune Effector Cell‐Associated Hematologic Toxicity After CD19 CAR ‐T Therapy: Incidence, Clinical Course, and Resource Utilization
by: Philippe Giguère, et al.
Published: (2026)

Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy
by: Patrick C. K. Tam, et al.
Published: (2026)

Research Advances in the Application of Aptamers for Hematologic Malignancies
by: Mingyan Wu, et al.
Published: (2026)

Targeting Oncogenic Drivers and Signaling Pathways in Hematologic Malignancies
Published: (2023)

Surgical Ophthalmic Oncology
Published: (2020)

Postoperative Care and Management in Pediatric Hematology‐Oncology Patients
by: Shachi Srivatsa, et al.
Published: (2026)

Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies
by: Amanda E. Marinoff, et al.
Published: (2025)

Emerging Techniques in Minimally Invasive Surgery in Hematologic Malignancies
by: Alejandro Chara, et al.
Published: (2025)

Concentration–QTc Analysis of Valemetostat in Patients With Hematologic Malignancies
by: Masaya Tachibana, et al.
Published: (2025)

Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings
by: Amrit S. Gonugunta, et al.
Published: (2026)

Outcomes of Wild Type and TP53 ‐Mutated B Cell Malignancy Patients Receiving CAR ‐T Cell Therapy: A Systematic Review and Meta‐Analysis
by: Wenxin Qi, et al.
Published: (2025)

Clinical Surgical Oncology
Published: (2024)

Recipient Cells Are the Source of Hematologic Malignancies After Graft Failure and Mixed Chimerism in Adults With SCD
by: Mohamed A. E. Ali, et al.
Published: (2025)

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies
by: Yan Sun, et al.
Published: (2025)

Building Pediatric Hematology/Oncology Workforce Capacity in Latin America
by: Daniel C. Moreira, et al.
Published: (2025)

Nanotechnology‐Assisted CAR‐T‐Cell Therapy for Tumor Treatment
by: Yixin Wang, et al.
Published: (2024)

Inpatient Food Insecurity and Pediatric Hematology Oncology Hospitalization Outcomes
by: Joanna M. Robles, et al.
Published: (2026)